Dr. Menter spoke with M.D./alert about the approval of Cosentyx in the treatment of patients age 6 and up for moderate-to-severe plaque psoriasis. He discusses the impact of this approval, particularly in the case of children and adolescents diagnosed with plaque psoriasis.
Please follow the link below to view Dr. Menter’s contribution, which is the first video on the page.

M.D./alert Conversations in Plaque Psoriasis (2021).